Empirical treatment of sepsis in neutropenic patients

Hospital Medicine

Volumn 62, Issue 2, 2001, Pages 101-103

  Klastersky, Jean ^a  

^a JULES BORDET INSTITUTE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; ANTIINFECTIVE AGENT;

AMBULATORY CARE; DRUG COMBINATION; HOSPITAL ADMISSION; HUMAN; NEUTROPENIA; PATIENT SELECTION; REVIEW; SEPSIS;

AMBULATORY CARE; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; DRUG THERAPY, COMBINATION; HUMANS; NEUTROPENIA; PATIENT ADMISSION; PATIENT SELECTION; SEPSIS;

EID: 0035258316     PISSN: 14623935     EISSN: None     Source Type: Journal    
DOI: 10.12968/hosp.2001.62.2.2089     Document Type: Article

References (4)

1. Kern W V, Cornelia A, de Bock R et al (1999) Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. .V Engl J Med 341: 312-8
2. Klastersky J, Paesmans M, Rubenstein EB et al (2000) For the Study Section on Infections, Multinational Association for Supportive Care in Cancer. The Multinational Association for Supportive Care in Cancer Risk Index: a Multinational Scoring System for Identifying low-risk febrile neutropenic cancer patients. J Clin Oncol 18(16): 3038-51
3. Rubenstein EB, Rolston K, Benjamin RS et al (1993) Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer. Cancer 71: 3640-6
4. Talcott JA. Siegel RD, Finberg R, Goldman L (1992) Risk assessment in cancer patients with fever and neutropenia : a prospective, two-center validation of a prediction rule. J Clin Oncol 10: 316-22